Open AccessBrief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated with Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results
Author(s) -
J.R. Arribas,
M. Thompson,
P.E. Sax,
B. Haas,
C. McDonald,
D.A. Wohl,
E. Dejesus,
A.E. Clarke,
S. Guo,
H. Wang,
C. Callebaut,
A. Plummer,
A. Cheng,
M. Das,
S. McCallister
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/0apm-zp62
Subject(s) - elvitegravir , cobicistat , tenofovir alafenamide , emtricitabine , human immunodeficiency virus (hiv) , medicine , virology , antiretroviral therapy , viral load